Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7236 Neoplasms 4537 Prostatic Neoplasms 3488 Colorectal Neoplasms 2937 Carcinoma, Non-Small-Cell Lung 2825 Lung Neoplasms 2544 Leukemia, Myeloid, Acute 1982 Pancreatic Neoplasms 1872 Multiple Myeloma 1808 Carcinoma, Hepatocellular 1731 Neoplasm Metastasis 1585 Stomach Neoplasms 1501 Lymphoma 1456 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1434 Head and Neck Neoplasms 1432 Brain Neoplasms 1368 Melanoma 1346 Ovarian Neoplasms 1340 Leukemia 1302 Rectal Neoplasms 1269 Recurrence 1252 Colonic Neoplasms 1204 Glioblastoma 1135 Uterine Cervical Neoplasms 1094 Lymphoma, Non-Hodgkin 1065 Leukemia, Lymphocytic, Chronic, B-Cell 989 Esophageal Neoplasms 964 Lymphoma, Follicular 936 Lymphoma, Large B-Cell, Diffuse 932 Squamous Cell Carcinoma of Head and Neck 921

Interventions

Mifepristone 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Gulf War Illness × Clear all

NCT04254627 2025-02-19

E/M

Nova Southeastern University

Phase 1 Active not recruiting

Gulf War Illness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡